Wound Care News and Research

RSS

Foot ulcers: One of the many challenges of diabetics

Diabetics face many health challenges, and among them is the risk of developing foot ulcers.

25 Nov 2009

Shareholders approve Derma Sciences' reverse stock split

Derma Sciences, Inc. a specialty medical device/pharmaceutical company focused on advanced wound care, announced today that its shareholders granted Derma Sciences' Board of Directors authority to implement a reverse stock split in the range of between 1-to-5 and 1-to-10.

25 Nov 2009

ConvaTec launches new web site on Hydrofiber Technology in Canada

ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced the launch in Canada of a new web site, www.Hydrofiber.ca, demonstrating how the company's proprietary Hydrofiber(R) Technology is transforming wound care.

24 Nov 2009

RBC Life Sciences reports net sales of $6.49M for third-quarter 2009

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain management products, reported today company-wide net sales of $6.49 million for the quarter ended September 30, 2009, compared to net sales of $9.93 million for the same quarter last year.

20 Nov 2009

Hemicorporectomy effective, and add years and quality of life to survivors

A landmark, 25-year review of cases in which surgeons had to remove the lower portion of the body from the waist down for severe pelvic bone infections shows the therapy can add years and quality of life to survivors, say researchers at UT Southwestern Medical Center.

20 Nov 2009

Advanced BioHealing commences efficacy trial of Dermagraft in the treatment of VLUs

Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that it has initiated a pivotal trial of Dermagraft® in subjects with venous leg ulcers (DEVO-Trial) to assess the product’s safety and efficacy in the promotion of healing venous leg ulcers (VLUs). Dermagraft is a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body’s natural healing process.

17 Nov 2009

SANUWAVE Health reports financial results for the three months ended September 30, 2009

SANUWAVE Health, Inc.,, an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports its achievements and financial results for the three and nine months ended September 30, 2009.

16 Nov 2009

Misonix inks a three-year distribution agreement with Xenith in Dubai

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Xenith, LLC, based in Dubai, UAE, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) Ultrasonic Bone Cutter, and the SonicOne® Ultrasonic Wound Debrider.

13 Nov 2009

FDA regulatory clearance for Kensey Nash's ECM product

Kensey Nash Corporation, a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance for its first extracellular matrix (ECM) product, Medeor(TM) Matrix, from the U.S. Food and Drug Administration.

12 Nov 2009

Positive results from Puricore's Vashe Wound Therapy efficacy trial

PuriCore, the life sciences company focused on developing and commercializing proprietary solutions that safely, effectively, and naturally kill infectious pathogens, today announced results of a randomized clinical trial showing the potential effectiveness of its Vashe Wound Therapy in the post-operative care of split-thickness skin grafts for burn injuries.

11 Nov 2009

Mesenchymal stem cells may be the key to healing diabetic foot ulcers

Diabetic foot ulcers are the primary cause of hospital admissions for diabetics. Foot ulcers that heal improperly are at risk for infection, which can lead to amputation. According to the American Diabetes Association, one in four patients with diabetic foot ulcers will eventually require lower-limb amputation. Now science has found a way of mobilizing stem cells within the body to treat this health issue, which affects more than three million Americans annually.

10 Nov 2009

Single reimbursement code for NPWT devices: Smith & Nephew endorses decision

The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc, applauded the federal government's decision last week to maintain the current, single reimbursement code for negative pressure wound therapy (NPWT) devices.

9 Nov 2009

Heal2gether Partnership Program for diabetes patients and their physicians launched

Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine and the maker of Dermagraft®, launched during American Diabetes Month the Heal2gether Partnership Program for diabetes patients and their physicians.

3 Nov 2009

Cardium Therapeutics to seek FDA marketing clearance for ExcellagenXL

Cardium Therapeutics today announced plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its ExcellagenXL(TM) product candidate.

3 Nov 2009

New on-line job resource center launched by NAWC

The National Alliance of Wound Care (NAWC(®)), the largest, multi-disciplinary, wound care credentialing and association organization, announced today, the launch of their wound care specialty on-line Job Resource Center in conjunction with their newly redesigned website at, www.nawccb.org.

2 Nov 2009

Prospera Technologies presents data on its Gauze vs. Foam based NPWT research

Prospera Technologies announced today that, at the Clinical Symposium on Advances in Skin & Wound Care in San Antonio, Texas, Oct 22-25, 2009, Malin Malmsjo MD., Ph.D. of Lund University in Lund, Sweden, presented significant new research comparing the differences and quality of granulation tissue in foam versus gauze based NPWT.

29 Oct 2009

Quebec City to host Conference of the Canadian Association of Wound Care

Quebec City this week hosts of one of Canada's largest health care conferences, as over 1,000 delegates meet at the annual Conference of the Canadian Association of Wound Care (CAWC).

27 Oct 2009

Bayshore Home Health acquires Nightingale Nursing Group

Bayshore Home Health announced today the purchase of Saskatoon-based home health care company Nightingale Nursing Group Inc. The acquisition expands Bayshore's presence in the province, complements its existing office in Regina, and provides an opportunity to service additional remote northern communities.

27 Oct 2009

Wound Management Technologies signs distribution agreement with Biocure S.r.l. of Milan

Wound Management Technologies, Inc., through its subsidiary, Wound Care Innovations, announced today that it has reached an agreement with Biocure S.r.l. of Milan, Italy for the distribution of WNDM's patented molecular form of activated collagen, CellerateRx®.

26 Oct 2009

ULURU presents clinical posters; highlights efficacy of Altrazeal dressing for wound care

ULURU Inc. (NYSE Alternext: ULU) today announced that Gregory Bohn, M.D., FACS, Medical Director, Trinity Wound Care and Hyperbaric Medicine, Bettendorf, Iowa, has presented nine clinical posters at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" being held in San Antonio, Texas.

24 Oct 2009